Table 1. Study design and statistical characteristics of included studies on MRCP, S-MRCP and EUS.
Author | Year | Location | Patients | Mean age (yr) | Men/Female | Reference standard | Tertiary center | TP | FP | FN | TN | Sens (%) | Spec (%) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MRCP | |||||||||||||
Kushnir VM et al.16 | 2013 | USA | 31 | 53 | 19/12 | ERCP | Yes | 9 | 1 | 6 | 15 | 60.0 | 93.8 |
Carnes ML et al.17 | 2008 | USA | 111 | 60 | 84/27 | ERCP | Partly | 39 | 0 | 57 | 15 | 40.6 | 100 |
Kamisawa T et al.18 | 2007 | Japan | 32 | NS | NS | ERCP | Yes | 11 | 0 | 4 | 17 | 73.3 | 100 |
Lai R et al.19 | 2004 | USA | 43 | 51 | NS | ERCP | Yes | 3 | 4 | 2 | 34 | 60 | 89.5 |
Manfredi R et al.20 | 2002 | Italy | 15 | 11.3 | NS | ERCP | Yes | 0 | 0 | 3 | 12 | 0 | 100 |
Matos C et al.21 | 2001 | Belgium | 279 | 51.4 | 171/108 | ERCP | Yes | 22 | 1 | 7 | 249 | 75.9 | 99.6 |
Manfredi R et al.10 | 2000 | Italy | 107 | 48 | 56/51 | ERCP | Yes | 4 | 1 | 5 | 97 | 44.4 | 99.0 |
Ueno E et al.22 | 1998 | Japan | 93 | NS | NS | ERCP | Yes | 4 | 0 | 5 | 84 | 44.4 | 100 |
Bret PM et al.23 | 1996 | Canada | 108 | NS | NS | ERCP | Yes | 6 | 0 | 0 | 102 | 100 | 100 |
Soto JA et al.24 | 1995 | USA | 37 | 53 | 14/23 | ERCP | Yes | 4 | 0 | 2 | 31 | 66.7 | 100 |
S-MRCP | |||||||||||||
Mosler P et al.25 | 2012 | USA | 113 | 47.1 | 54/59 | ERCP | Yes | 14 | 3 | 5 | 91 | 73.7 | 96.8 |
Carnes ML et al.17 | 2008 | USA | 111 | 60 | 84/27 | ERCP | Yes | 10 | 0 | 5 | 96 | 66.7 | 100 |
Manfredi R et al.20 | 2002 | Italy | 15 | 11.3 | NS | ERCP | Yes | 2 | 0 | 1 | 12 | 66.7 | 100 |
Matos C et al.21 | 2001 | Belgium | 279 | 51.4 | 171/108 | ERCP | Yes | 29 | 1 | 1 | 248 | 96.7 | 99.6 |
Manfredi R et al.10 | 2000 | Italy | 107 | 48 | 56/51 | ERCP | Yes | 8 | 3 | 1 | 95 | 88.9 | 96.9 |
EUS | |||||||||||||
Kushnir VM et al.16 | 2013 | USA | 45 | 53.8 | 13/32 | ERCP | Yes | 39 | 0 | 6 | 3 | 86.7 | 100 |
Romagnuolo J et al.26 | 2013 | USA | 36 | 55 | 16/20 | ERCP | Yes | 18 | 1 | 3 | 3 | 85.7 | 75 |
Rana SS et al.27 | 2013 | India | 146 | 36.9 | 102/44 | ERCP | Yes | 16 | 4 | 0 | 126 | 100 | 96.9 |
Ortega AR et al.28 | 2011 | Spain | 49 | 58 | 24/25 | Unclear | Yes | 1 | 0 | 3 | 45 | 25 | 100 |
Lai R et al.19 | 2004 | USA | 127 | 51 | NS | ERCP | Yes | 18 | 3 | 1 | 105 | 94.7 | 97.2 |
Tandon M et al.29 | 2001 | USA | 31 | 48.8 | 12/19 | ERCP | Partly | 2 | 0 | 1 | 28 | 66.7 | 100 |
Bhutani MS et al.30 | 1999 | USA | 36 | NS | NS | ERCP | Yes | 4 | 5 | 2 | 25 | 66.7 | 83.3 |